Skip to main content

Clinically proven results

When considering any treatment, you want to dig into the research. SpaceOAR has demonstrated safety and efficacy in its clinical trial. SpaceOAR Hydrogel works by temporarily creating space between the prostate and the rectum during the course of your radiation treatment. This small amount of space may help reduce radiation exposure to the rectum, potentially decreasing damaging side effects.

Male symbol icon.

Fewer sexual complications

SpaceOAR Hydrogel patients who had erections sufficient for intercourse at baseline were 67% more likely to retain erectile function at three years.1

Bladder icon.

Fewer urinary complications

The use of SpaceOAR Hydrogel reduced the likelihood of more serious changes in urinary quality of life by 60% compared to those in the control group.2

Bowel icon.

Fewer bowel complications

At three years, grade 1 rectal toxicity was decreased by 75% in patients treated with SpaceOAR Hydrogel versus the control group.2

325,000

Patients have been treated and that number is growing with SpaceOAR Hydrogel Portfolio*

10/10

SpaceOAR products have been purchased at 10 of the top 10 cancer centers†

Learn what doctors are saying about SpaceOAR

Icon of 3 people.

Learn why patients choose SpaceOAR Hydrogel

Go to patient stories
FAQ icon.

Frequently asked questions

Explore FAQ
Icon of a document.

View and download brochure

Download now

*Number of patients is based on units shipped and a BSC proprietary algorithm.
†Data based on sales for SpaceOAR™ Hydrogel or SpaceOAR Vue™ Hydrogel to institutions in 2024.

References

  1. Hamstra DA, Mariados N, Sylvester J, et al. Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial. Pract Radiat Oncol. 2018 Jan-Feb;8(1):e7–e15.
  2. Hamstra DA, Mariados N, Sylvester J, et al. Continued benefit to rectal separation for prostate radiation therapy: Final results of a phase III trial. Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):976–85.

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.

Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

SpaceOAR Hydrogel is intended to temporarily move the rectal wall away from the prostate during the course of radiotherapy treatment for prostate cancer, and in creating this space it is the intent of SpaceOAR Hydrogel to reduce the radiation dose affecting the rectum.

SpaceOAR Hydrogel contains polyethylene glycol (PEG). As with any medical treatment, there are some risks involved with the use of SpaceOAR Hydrogel. Potential complications associated with SpaceOAR Hydrogel include, but are not limited to: pain associated with injection, pain or discomfort from the hydrogel, site inflammation, infection (including abscess), inability to urinate, urgent need to urinate, constipation, rectal muscle spasm, damage to lining of rectum, ulcers, fistula (a hole between rectum and bladder, urethra, or skin below the scrotum), perforation (hole in prostate, bladder, urethra, rectum), necrosis (dead tissue), allergic reaction (local reaction or more severe reaction, such as anaphylaxis), embolism (blood vessel blockage is possible and may happen outside of the pelvis, potentially impacting vital organs or legs), fainting, and bleeding. Please talk to your doctor about the risks and benefits related to using SpaceOAR Hydrogel. If one or more of these complications occur, you may need medical treatment or surgery. 

All images are the property of Boston Scientific.